EP1668133A4 - Coiled-coil fusion proteins comprising cell receptor domains - Google Patents
Coiled-coil fusion proteins comprising cell receptor domainsInfo
- Publication number
- EP1668133A4 EP1668133A4 EP04761779A EP04761779A EP1668133A4 EP 1668133 A4 EP1668133 A4 EP 1668133A4 EP 04761779 A EP04761779 A EP 04761779A EP 04761779 A EP04761779 A EP 04761779A EP 1668133 A4 EP1668133 A4 EP 1668133A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- coiled
- fusion proteins
- cell receptor
- receptor domains
- coil fusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50085503P | 2003-09-05 | 2003-09-05 | |
PCT/CA2004/001616 WO2005024035A1 (en) | 2003-09-05 | 2004-09-02 | Coiled-coil fusion proteins comprising cell receptor domains |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1668133A1 EP1668133A1 (en) | 2006-06-14 |
EP1668133A4 true EP1668133A4 (en) | 2007-08-29 |
Family
ID=34273005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04761779A Withdrawn EP1668133A4 (en) | 2003-09-05 | 2004-09-02 | Coiled-coil fusion proteins comprising cell receptor domains |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1668133A4 (en) |
JP (1) | JP2007503820A (en) |
AU (1) | AU2004270774A1 (en) |
CA (1) | CA2536936A1 (en) |
WO (1) | WO2005024035A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070184052A1 (en) * | 2003-05-09 | 2007-08-09 | Lin Herbert Y | Soluble tgf-b type III receptor fusion proteins |
WO2005086598A2 (en) | 2004-03-18 | 2005-09-22 | Lg Electronics Inc. | Apparatus and method for recording and/or reproducing data to/from recording medium |
US7710853B2 (en) | 2004-03-18 | 2010-05-04 | Lg Electronics, Inc. | Recording medium with segment information thereon and apparatus and methods for forming, recording, and reproducing the recording medium |
TWI381374B (en) | 2004-03-18 | 2013-01-01 | Lg Electronics Inc | Recording medium with overlapping segment information thereon and apparatus and methods for forming, recording, and reproducing the recording medium |
EP2491391B1 (en) * | 2009-10-23 | 2018-02-28 | GE Healthcare Bio-Sciences AB | Method for determination of macromolecular multimers |
WO2012071649A1 (en) * | 2010-11-29 | 2012-06-07 | National Research Council Of Canada | Covalently dimerized bivalent binding agents |
CA3041727A1 (en) * | 2016-11-18 | 2018-05-24 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Engineered tgf-beta monomers and their use for inhibiting tgf-beta signaling |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997012988A1 (en) * | 1995-10-06 | 1997-04-10 | Pence | Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6472179B2 (en) * | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
WO2000047612A2 (en) * | 1999-02-11 | 2000-08-17 | Xencor, Inc. | Structure-based screening techniques for drug discovery |
-
2004
- 2004-09-02 EP EP04761779A patent/EP1668133A4/en not_active Withdrawn
- 2004-09-02 CA CA002536936A patent/CA2536936A1/en not_active Abandoned
- 2004-09-02 AU AU2004270774A patent/AU2004270774A1/en not_active Abandoned
- 2004-09-02 JP JP2006525014A patent/JP2007503820A/en not_active Abandoned
- 2004-09-02 WO PCT/CA2004/001616 patent/WO2005024035A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997012988A1 (en) * | 1995-10-06 | 1997-04-10 | Pence | Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins |
Non-Patent Citations (7)
Also Published As
Publication number | Publication date |
---|---|
AU2004270774A1 (en) | 2005-03-17 |
WO2005024035A1 (en) | 2005-03-17 |
CA2536936A1 (en) | 2005-03-17 |
JP2007503820A (en) | 2007-03-01 |
EP1668133A1 (en) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL166751A0 (en) | Modified transferin-antibody fusion proteins | |
PL1830872T3 (en) | Fusion proteins | |
GB0426397D0 (en) | Fusion proteins | |
EP1688439A4 (en) | Fused protein composition | |
IL166750A0 (en) | Modified transferrin fusion proteins | |
AU2003239365A8 (en) | Recombinant glycosyltransferase fusion proteins | |
EP1594530A4 (en) | Albumin fusion proteins | |
IL176894A0 (en) | Albumin fusion proteins | |
ZA200702004B (en) | Binding domain fusion proteins | |
ZA201004902B (en) | Erythropoietin receptor binding antibodies | |
ZA200502981B (en) | Erythropoietin receptor binding antibodies | |
EP1499352A4 (en) | Recombinant anti-interleukin-9 antibodies | |
EP1497649A4 (en) | Antibodies specific for mucin polypeptide | |
EP1668133A4 (en) | Coiled-coil fusion proteins comprising cell receptor domains | |
AU2003226131A8 (en) | Novel human cell surface protein with immunoglobulin folds, bgs-19 | |
EP1409517A4 (en) | Fusion proteins based upon somatostatin receptors | |
AU2003237332A8 (en) | Anti-relp fusion antibodies, compositions, methods and uses | |
GB0306428D0 (en) | Receptor proteins | |
GB0425368D0 (en) | T cell receptor fusion proteins | |
AU2003239777A8 (en) | Multimerised growth hormone fusion proteins | |
NO20021244L (en) | Subunit-optimized fusion proteins | |
GB0502681D0 (en) | T cell receptor fusion proteins | |
GB0315252D0 (en) | Receptor proteins | |
GB0220459D0 (en) | Receptor proteins | |
GB0223877D0 (en) | Receptor proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060330 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 38/00 20060101ALN20070511BHEP Ipc: G01N 33/53 20060101ALN20070511BHEP Ipc: C07K 14/71 20060101ALI20070511BHEP Ipc: C12N 15/62 20060101AFI20050331BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20070727 |
|
17Q | First examination report despatched |
Effective date: 20071015 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20081008 |